Luminex and Other Multiplex High Throughput Technologies for the Identification of, and Host Response to, Environmental Triggers of Type 1 Diabetes

Complex interactions between a series of environmental factors and genes result in progression to clinical type 1 diabetes in genetically susceptible individuals. Despite several decades of research in the area, these interactions remain poorly understood. Several studies have yielded associations of certain foods, infections, and immunizations with the onset and progression of diabetes autoimmunity, but most findings are still inconclusive. Environmental triggers are difficult to identify mainly due to (i) large number and complex nature of environmental exposures, including bacteria, viruses, dietary factors, and environmental pollutants, (ii) reliance on low throughput technology, (iii) less efforts in quantifying host response, (iv) long silent period between the exposure and clinical onset of T1D which may lead to loss of the exposure fingerprints, and (v) limited sample sets. Recent development in multiplex technologies has enabled systematic evaluation of different classes of molecules or macroparticles in a high throughput manner. However, the use of multiplex assays in type 1 diabetes research is limited to cytokine assays. In this review, we will discuss the potential use of multiplex high throughput technologies in identification of environmental triggers and host response in type 1 diabetes.

[1]  A. Hämäläinen,et al.  Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study , 2005, Diabetologia.

[2]  D. James,et al.  Use of Luminex xMAP-derived Bio-Plex bead-based suspension array for specific detection of PPV W and characterization of epitopes on the coat protein of the virus. , 2008, Journal of virological methods.

[3]  M. Rewers,et al.  An exploration of Glo‐3A antibody levels in children at increased risk for type 1 diabetes mellitus , 2009, Pediatric diabetes.

[4]  J. She,et al.  Proteomic Technologies for the Discovery of Type 1 Diabetes Biomarkers , 2010, Journal of diabetes science and technology.

[5]  F. Egro Why is type 1 diabetes increasing? , 2013, Journal of molecular endocrinology.

[6]  J. Jackson,et al.  Enteroviruses, type 1 diabetes and hygiene: a complex relationship , 2010, Reviews in medical virology.

[7]  J. Ilonen,et al.  Enterovirus infections are associated with the induction of β‐cell autoimmunity in a prospective birth cohort study , 2003, Journal of medical virology.

[8]  J. Neu,et al.  The “Perfect Storm” for Type 1 Diabetes , 2008, Diabetes.

[9]  N. Sakly,et al.  Anti-Saccharomyces cerevisiae Antibodies are Frequent in Type 1 Diabetes , 2010, Endocrine pathology.

[10]  O. Simell,et al.  A Type 1 Diabetes-related Protein from Wheat (Triticum aestivum) , 2003, The Journal of Biological Chemistry.

[11]  J. She,et al.  Serum insulin-like growth factor binding protein 6 (IGFBP6) is increased in patients with type 1 diabetes and its complications. , 2012, International journal of clinical and experimental medicine.

[12]  E. Bonifacio,et al.  Natural history of type 1 diabetes. , 2005, Diabetes.

[13]  J J Couper,et al.  Environmental triggers of type 1 diabetes , 2001, Journal of paediatrics and child health.

[14]  S. Virtanen,et al.  Environmental triggers and determinants of type 1 diabetes. , 2005, Diabetes.

[15]  F. Dotta,et al.  Viral infections and diabetes. , 2012, Advances in experimental medicine and biology.

[16]  J. N. Figueiroa,et al.  Breastfeeding protects against type 1 diabetes mellitus: a case-sibling study. , 2012, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

[17]  J. Ludvigsson,et al.  Does modern high standard life style cause type 1 diabetes in children? , 2013, Diabetes/metabolism research and reviews.

[18]  J. Norris Infant and Childhood Diet and Type 1 Diabetes Risk: Recent Advances and Prospects , 2010, Current diabetes reports.

[19]  Kathrin U. Jansen,et al.  Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex Assay , 2003, Clinical Diagnostic Laboratory Immunology.

[20]  Z. Duan,et al.  Simultaneous Detection of Seven Enteric Viruses Associated with Acute Gastroenteritis by a Multiplexed Luminex-Based Assay , 2012, Journal of Clinical Microbiology.

[21]  A. Cooke Review series on helminths, immune modulation and the hygiene hypothesis: How might infection modulate the onset of type 1 diabetes? , 2009, Immunology.

[22]  J. Tuomilehto,et al.  Cumulative incidence of type 1 diabetes in 10,168 siblings of Finnish young-onset type 1 diabetic patients. , 2005, Diabetes.

[23]  J. She,et al.  Chemokine (C-C Motif) Ligand 2 (CCL2) in Sera of Patients with Type 1 Diabetes and Diabetic Complications , 2011, PloS one.

[24]  P. Wakeley,et al.  Development and evaluation of a Luminex multiplex serology assay to detect antibodies to bovine herpes virus 1, parainfluenza 3 virus, bovine viral diarrhoea virus, and bovine respiratory syncytial virus, with comparison to existing ELISA detection methods. , 2011, Journal of immunological methods.

[25]  G. d’Annunzio,et al.  In Type 1 Diabetes a Subset of Anti-Coxsackievirus B4 Antibodies Recognize Autoantigens and Induce Apoptosis of Pancreatic Beta Cells , 2013, PloS one.

[26]  R. Alfenas,et al.  Does breastfeeding influence the risk of developing diabetes mellitus in children? A review of current evidence. , 2014, Jornal de pediatria.

[27]  Robert Podolsky,et al.  Assessing the utility of SELDI‐TOF and model averaging for serum proteomic biomarker discovery , 2006, Proteomics.

[28]  O. Vaarala Leaking gut in type 1 diabetes , 2008, Current opinion in gastroenterology.

[29]  I. Thorsdottir,et al.  Whole cow's milk in early life. , 2011, Nestle Nutrition workshop series. Paediatric programme.

[30]  M. Peakman,et al.  Enteroviruses and type 1 diabetes , 2003, Diabetes/metabolism research and reviews.

[31]  M. V. von Herrath,et al.  Viral Trigger for Type 1 Diabetes , 2008, Diabetes.

[32]  J. She,et al.  Advances and challenges in biomarker development for type 1 diabetes prediction and prevention using omic technologies. , 2010, Expert opinion on medical diagnostics.

[33]  Jennifer C. Drew,et al.  Toward defining the autoimmune microbiome for type 1 diabetes , 2011, The ISME Journal.

[34]  M. Nahm,et al.  Development of an Automated and Multiplexed Serotyping Assay for Streptococcus pneumoniae , 2011, Clinical and Vaccine Immunology.

[35]  J. She,et al.  Discovery and Validation of Serum Protein Changes in Type 1 Diabetes Patients Using High Throughput Two Dimensional Liquid Chromatography-Mass Spectrometry and Immunoassays* , 2011, Molecular & Cellular Proteomics.

[36]  J. She,et al.  Biomarkers for type 1 diabetes. , 2008, International journal of clinical and experimental medicine.

[37]  A. Hämäläinen,et al.  Dietary intervention in infancy and later signs of beta-cell autoimmunity. , 2010, The New England journal of medicine.

[38]  G. Kuchel,et al.  ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[39]  L. Greco,et al.  Gluten Sensitivity in a Subset of Children With Insulin Dependent Diabetes Mellitus , 2003, American Journal of Gastroenterology.

[40]  E. Bonifacio,et al.  Insulin autoantibodies with high affinity to the bovine milk protein alpha casein , 2011, Clinical and experimental immunology.

[41]  信一 高尾,et al.  ヒト呼吸器系ウイルスの検出における呼吸器系ウイルス多項目同時解析アッセイ (Luminex xTAG Respiratory Viral Panel FAST Assay) の有用性の検討 , 2011 .

[42]  Z. M. I. Dezayee The status of serum γ-interferonand antiviral antibodies in patients with type I and type 2 diabetes: A comparative study , 2012, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[43]  J. Dillner,et al.  No evidence of enteroviruses in the intestine of patients with type 1 diabetes , 2012, Diabetologia.

[44]  J. Hillebrands,et al.  Viral infections as potential triggers of type 1 diabetes , 2007, Diabetes/metabolism research and reviews.

[45]  E. Bonifacio,et al.  Age- and Islet Autoimmunity–Associated Differences in Amino Acid and Lipid Metabolites in Children at Risk for Type 1 Diabetes , 2011, Diabetes.

[46]  N. Chapman,et al.  Enteroviruses and type 1 diabetes , 2011, Diabetes/metabolism research and reviews.

[47]  S. Eckenrode,et al.  The application of genomic and proteomic technologies in predictive, preventive and personalized medicine. , 2006, Vascular pharmacology.